IR-Med, Inc.

Monster Motors, Inc. operates as a holding company for its Israeli operating subsidiary, IR. Med Ltd., which was founded in 2013. The company's corporate headquarters and research facilities are located at ZHR Industrial Zone, Rosh Pina, Israel. Monster Motors, Inc. is developing point-of-care decision support devices utilizing a patented infrared spectroscopy and artificial intelligence (AI) analysis technology platform. This electrooptic visual and infrared spectroscopy technology platform non-invasively gathers bio-information from a patient's blood and tissue, which is then analyzed by AI-based algorithms to assist healthcare professionals in assessing and monitoring various disease conditions. The company's primary focus is on the DiaSafe™ device and the production of commercial units. Its first product based on this platform is PressureSafe™, a handheld device designed for the early assessment of pressure injuries (PIs) affecting skin and underlying tissue. PIs in the U.S. account for $26.8 billion in healthcare spending and result in 60,000 deaths annually. PressureSafe™ aims to provide early PI assessment regardless of patient skin tone. The company plans to launch PressureSafe™ as a decision support system (DSS) tool for caregivers in hospitals, nursing homes, and home-care companies. On April 9, 2024, the PressureSafe™ device received FDA listing certification and is classified as a Class I device. The company is completing the development of the commercial version of PressureSafe™, with initial sales planned during the second half of 2025.